Astarte Medical scores $5 mln Series A
Yardley, Pennsylvania-based Astarte Medical, a precision medicine company using software and predictive analytics to improve premature infant outcomes, has secured $5 million in Series A financing. The investors included Viking Global Investors LP, Lunsford Capital, OCA Ventures, Keiretsu Forum MidAtlantic, Keiretsu Capital Fund, Ben Franklin Technology Partners, Wing VC and Next Act Fund.
7 May 2019•1 min read
